Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04187703
Title 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Benjamin Tomlinson
Indications

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

Therapies

Azacitidine + Decitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.